Quinoxaline

Names

[ CAS No. ]:
91-19-0

[ Name ]:
Quinoxaline

[Synonym ]:
Quinoxaline
1,4-Benzodiazine
EINECS 202-047-4
Benzopyrazine
1,4-Diazanaphthalene
MFCD00006719
Phenopiazine
Phenpiazine
Benzoparadiazine
Quinazine

Chemical & Physical Properties

[ Density]:
1.2±0.1 g/cm3

[ Boiling Point ]:
229.5±0.0 °C at 760 mmHg

[ Melting Point ]:
29-32 °C(lit.)

[ Molecular Formula ]:
C₈H₆N₂

[ Molecular Weight ]:
130.147

[ Flash Point ]:
98.3±0.0 °C

[ Exact Mass ]:
130.053101

[ PSA ]:
25.78000

[ LogP ]:
1.30

[ Vapour Pressure ]:
0.1±0.4 mmHg at 25°C

[ Index of Refraction ]:
1.653

[ Storage condition ]:
2-8°C

[ Water Solubility ]:
SOLUBLE

MSDS

Click to get detail MSDS

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :: VD1225000

CHEMICAL NAME :: Quinoxaline

CAS REGISTRY NUMBER :: 91-19-0

LAST UPDATED :: 199701

DATA ITEMS CITED :: 3

MOLECULAR FORMULA :: C8-H6-N2

MOLECULAR WEIGHT :: 130.16

WISWESSER LINE NOTATION :: T66 BN ENJ

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 250 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: NTIS** National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific & Technical Information. Volume(issue)/page/year: AD607-952

Safety Information

[ Hazard Codes ]:
Xi:Irritant;

[ Risk Phrases ]:
R36/37/38

[ Safety Phrases ]:
S26-S36

[ RIDADR ]:
NONH for all modes of transport

[ WGK Germany ]:
3

[ RTECS ]:
VD1225000

[ HS Code ]:
29339990

Synthetic Route

Click to get detail synthetic route

Precursor & DownStream

Precursor

DownStream

Customs

[ HS Code ]: 2933990090

[ Summary ]:
2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

Articles

Pharmacokinetics of raltegravir in the semen of HIV-infected men.

Antivir. Ther. (Lond.) 19(6) , 607-11, (2014)

We sought to determine the pharmacokinetic disposition of raltegravir in the blood and seminal plasma of HIV-infected men.We conducted a pharmacokinetic study using a staggered sampling approach. A to...